Here are eight things to know:
1. Zimmer Biomet reported fourth quarter net sales of $2.013 billion, which translates to a 4.1 percent increase from 2015.
2. Q4 revenue increased by 3.5 percent compared to 2015’s Q4 revenue numbers.
3. The company reported that 2016 net sales totaled $7.684 billion, a 28.1 percent increase from its 2015 net sales.
4. David Dvorak, president and CEO of Zimmer Biomet, attributed the revenue growth to the knee and hip businesses’ success, the various categories’ strengths, and the company’s continued ability to achieve its goals in the Asia Pacific region.
5. Q4’s net earnings of $66.6 million decreased 47.5 percent from the previous year.
6. Zimmer Biomet reported that full-year 2016 earnings totaled $302.9 million, an increase of 106 percent compared to 2015’s earnings.
7. The company’s 2016 operating cash flow was $1.632 billion.
8. Zimmer Biomet is an orthopedic device company based in Warsaw, Ind.
More articles on devices:
5 key points on Trump’s meeting with pharma execs
FDA premarket approvals dropped 51% in 2016 — but 2017 shaping up differently: 5 key notes
Stryker shares update — 7 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
